Organogenesis Holdings (ORGO) Change in Account Payables (2018 - 2026)

Organogenesis Holdings' Change in Account Payables history runs 9 years deep, the most recent figure standing at -$2.0 million for Q1 2026.

• On a quarterly basis, Change in Account Payables rose 19.75% year-over-year to -$2.0 million in Q1 2026; TTM through Mar 2026 was -$35000.0, a 92.66% increase from a year earlier, with the FY2025 full-year figure at -$528000.0, up 77.74% from the prior year.
• Change in Account Payables slipped to -$2.0 million in Q1 2026 per ORGO's latest filing, from -$1.2 million in the prior quarter.
• Across five years, Change in Account Payables topped out at $4.1 million in Q2 2025 and bottomed at -$4.4 million in Q1 2024.
• The 5-year median for Change in Account Payables is -$1.2 million (2025), against an average of -$103000.0.
• Across the five-year window, Change in Account Payables soared 442.54% in 2022 and plunged 2975.4% in 2024, its largest moves.
• Year by year, Change in Account Payables stood at -$2.0 million in 2022, then soared by 277.56% to $3.6 million in 2023, then increased by 2.73% to $3.6 million in 2024, then sank by 132.08% to -$1.2 million in 2025, then sank by 71.05% to -$2.0 million in 2026.
• Per Business Quant, the three latest ORGO Change in Account Payables figures stand at -$2.0 million (Q1 2026), -$1.2 million (Q4 2025), and -$994000.0 (Q3 2025).